Erythrocyte protoporphyrin (EPP) concentration was determined in 87 children who presented at the Adeoyo General Hospital and the University Teaching Hospital (Ibadan, Nigeria) for various ailments. Presence or absence of anaemia was based on haemoglobin concentration. There was a significant difference (p < 0.01) between the mean haemoglobin values of the severely anaemic, mildly anaemic and control children. There was no significant difference (p > 0.05) between the mean haematocrit, mean EPP and mean EPP:Hb ratio of the mildly anaemic and control groups, but corresponding values for the severely anaemic group differed significantly (p < 0.001) from the values for the others. The increase in EPP was correlated with the decrease in Hb concentration(r = -0.8263, p < 0.001), suggesting that iron deficiency was a major cause of severe anaemia. EPP alone or in combination with Hb is effective in identifying anaemic individuals, while Hb alone tends to over-estimate the occurrence of iron deficiency anaemia. EPP values above 100 µg/100 ml of erythrocytes identified severe anaemia.

Keywords:
Erythrocyte protoporphyrin, Haemoglobin, Iron deficiency anaemia
This content is only available via PDF.
© 1986 S. Karger AG, Basel
1986
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.